Australia consults on fees under new biologicals framework
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration has proposed fee rates for evaluating applications under the new biologicals framework that covers human cell and tissue therapy products (HCTs). The framework was signed into law earlier this year and will enter into force on 31 May 2011 (www.clinica.co.uk, 7 June 2010).